× ×ª×× × ×ª×¨×פ×
××רש×
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L01FX
Other monoclonal antibodies and antibody drug conjugates
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
ת××-×ר××× - I.V
|
| צ×רת ××× ××
|
תר××× ×××× ×ª ת×××¡× ×××× ×¤××××, CONCENTRATE FOR SOLUTION FOR INFUSION
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
Hepatocellular CarcinomaIMJUDO in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (HCC).Non-Small Cell Lung Cancer (NSCLC)IMJUDO in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic NSCLC with no sensitising EGFR mutations or ALK positive mutations.
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 17/03/2024
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ×. Tremelimumab (×××××ר ×ר×ש×× ×××פ××) ×ש×××× ×¢× Durvalumab, ×××פ×× ×סר×× ×פ××צ×××××¨× ×× × ×ª×× ×× ×ר×רת×, ×××××× ×©××¨× ×§×××× ××פ×× ×¡×ס××× ××××ת×. ××××× ××××ª× ×××× ××××× ×××× ×××ת ××תר×פ×ת ××××ת â Atezolizumab + Bevacizumab, Lenvatinib, Sorafenib, Durvalumab + Tremelimumab. ××××× ××××ª× ×××× ××××× ×××× ×תר××¤× ××ת ×××× ×תר×פ×ת ××שת××××ת ××שפ×ת ×-Checkpoint inhibitors (××¢× ××× ×× ×©×××× Durvalumab ×¢× Tremelimumab ×××©× ×ª×¨××¤× ××ת). ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§××××××.
|
17/03/2024 |
××× ×§×××××× |
|
סר×× ×פ××צ××××ר×, Hepatocellular cancer |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- ×. Tremelimumab (×××××ר ×ר×ש×× ×××פ××) ×ש×××× ×¢× Durvalumab, ×××פ×× ×סר×× ×פ××צ×××××¨× ×× × ×ª×× ×× ×ר×רת×, ×××××× ×©××¨× ×§×××× ××פ×× ×¡×ס××× ××××ת×.××××× ××××ª× ×××× ××××× ×××× ×××ת ××תר×פ×ת ××××ת â Atezolizumab + Bevacizumab, Lenvatinib, Sorafenib, Durvalumab + Tremelimumab. ××××× ××××ª× ×××× ××××× ×××× ×תר××¤× ××ת ×××× ×תר×פ×ת ××שת××××ת ××שפ×ת ×-Checkpoint inhibitors (××¢× ××× ×× ×©×××× Durvalumab ×¢× Tremelimumab ×××©× ×ª×¨××¤× ××ת).
- ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§××××××.
|
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
Â
Â
|
| ××פ×ש ×××ר××
|
×××ר×× ×-PubMed
|
| ××××¢ ×רשת
|
RxList WebMD Drugs.com
|
| ×©× ×צר×
|
VETTER PHARMA-FERTIGUNG GMBH & CO. KG, GERMANY
|
| ×©× ××¢× ×ר×ש××
|
ASTRAZENECA (ISRAEL) LTD
|
| ר×ש×××
|
ת×ר×× ××ש×: 12/2022. ר×ש××× ×ת×ר××:
|
| ת×ר×× ×¢×××× ××ר××
|
24/07/2024
|
ת××× ×ª ×ר×××
ת×ר×× ×¢××××: 24/07/2024
VETTER
××××'××× - Imjudo
true
השינוי האחרון נעשה בֹ־20 במאי 2025 ב־10:16
